Two urologists have been appointed to new positions at the University of Kentucky College of Medicine, Lexington. Stephen Strup, MD, has been appointed as chief of the division of urology, and Randall Rowland, MD, as CEO and president of the The Markey Cancer Foundation.
Two urologists have been appointed to new positions at the University of Kentucky College of Medicine, Lexington. Stephen Strup, MD, has been appointed as chief of the division of urology, and Randall Rowland, MD, as CEO and president of the The Markey Cancer Foundation.
"My goals are to advance the excellent division that Dr. Randall Rowland has crafted," said Dr. Strup, who is currently an associate professor of surgery in the division of urology and the William Stamps Farish Chair of Urologic Research. "We want to continue to raise our national profile and be regarded as a program that is able to maintain the delicate balance of teaching, research, and clinical care."
Since joining the University of Kentucky in 2003, Dr. Strup has established programs for minimally invasive surgery and robotic urologic surgery. He also established and serves as co-director for a fellowship in minimally invasive surgery and endourology and is the university’s urology residency program director.
Dr. Rowland, currently a professor of surgery and the James F. Glenn Chair of Urology, has been at the University of Kentucky for 10 years.
"My goal is to re-energize the Markey Cancer Foundation and its board to support the Markey Cancer Center in this time of growth opportunity," he said. "I look forward to challenges and opportunities on the horizon while working with a very strong staff and board of the Markey Cancer Foundation."
Dr. Rowland has been honored with the Ben Eiseman Surgery Teaching Award for Excellence in Residency Education by the department of surgery.
Separately, Joseph G. Barone, MD, has been named the new chief of the division of urology at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School in New Brunswick. Dr. Barone also holds the position of chief, pediatric urology, and surgeon-in-chief, division of pediatric surgery at the Bristol-Myers Squibb Children’s Hospital, also in New Brunswick.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.